Arca Biopharma reported $941.49M in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
Amgen USD 34.36B 598M Sep/2026
Arca Biopharma USD 941.49M 56.93M Sep/2026
Biogen USD 7.58B 278.7M Sep/2026
Brainstorm Cell Therapeutics USD 316K 132K Jun/2026
Bristol-Myers Squibb USD 29.77B 1.19B Sep/2026
Capricor Therapeutics USD 202.25M 39.88M Sep/2026
Cipla INR 250.61B 9.14B Sep/2026
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 129.41M 7.88M Jun/2026
CSL USD 11.85B 1000K Dec/2025
Cytokinetics USD 1.19B 21.34M Sep/2026
Daiichi Sankyo JPY 2.38T 150.33B Sep/2026
Gilead Sciences USD 16.55B 4.02B Sep/2026
GlaxoSmithKline GBP 17.9B 336M Sep/2026
Grifols EUR 5.96B 316.31M Dec/2025
Laboratory Of America USD 3.97B 151.3M Sep/2026
Myriad Genetics USD 289M 23.8M Jun/2026
Otsuka Holdings JPY 1.6T 29.58B Sep/2026
Pfizer USD 45.01B 3.65B Sep/2026
United Therapeutics USD 2.88B 603.5M Sep/2026